Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretideâ„¢ or Advair ®) is low. However, when asthma control deteriorates ...
Seretide (salmeterol xinafoate/fluticasone propionate) – sold as Advair in the US and other markets – is the top-selling inhaled beta agonist and corticosteroid combination therapy in the UK.
These data provide reassurance to prescribers that doubling the dose of Seretide™ for a short period of time is unlikely to result in any clinically relevant β 2-agonist- or inhaled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback